* Oracle Diagnostics Inc., of Foster City, Calif., named Bert DelVillano executive vice president of marketing and businessdevelopment.* Biomira Inc., of Edmonton, Canada, appointed Dennis Schneck vicepresident of clinical and regulatory affairs.* Harrier Inc., of Los Angeles, named the following to its scientificadvisory board: Daniel Von Hoff, of the University of Texas HealthScience Center, San Antonio; Masato Koreeda, of the University ofMichigan, Ann Arbor; and Peter Carroll, of Tufts University, Boston.* Univax Biologics Inc., of Rockville, Md., appointed Judith Hautalavice president of corporate communications and planning.* Signal Pharmaceuticals Inc., of San Diego, named Bradley Gordon asvice president of finance and chief financial officer.* Matritech Inc., of Cambridge, Mass., appointed Dev Purkayastha, ofSan Diego-based Idanta Partners Ltd., to the board of directors.* Houghten Pharmaceuticals Inc., of San Diego, named TerenceMcMorrow vice president of finance and corporate development.* Quintiles Transnational Corp., of Research Triangle Park, N.C.,appointed Arthur Pappas, a health care and life sciences consultant, tothe board of directors.* Cambridge NeuroScience Inc., of Cambridge, Mass., named NancyAmer, of Harvard Private Capital Group Inc., to the board of directors.091294A&A

(c) 1997 American Health Consultants. All rights reserved.